A phase I dose escalation trial in healthy volunteers to assess safety and tolerability
Latest Information Update: 03 Aug 2021
At a glance
- Drugs DIOS-203 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; First in man
- 03 Aug 2021 New trial record